3 Regeneron Pharmaceuticals Filers Filed Intent to Sell 3,461 Shares (~$2.9M)
Regeneron Pharmaceuticals (REGN) had 3 Form 144 pre-sale notices filed on 2026-10-30. Form 144 filings signal an insider's intent to sell securities under SEC Rule 144 — they do not confirm a completed transaction. At…